Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure.

This study provides data on plasma hormone levels in patients with severe clinical congestive cardiac failure who had never received therapy and in whom the presence of an accumulation of excess water and sodium had been established. Eight patients were studied; two had ischemic cardiac disease, and six had dilated cardiomyopathy. Mean hemodynamic measurements at rest were as follows: cardiac index, 1.8 l/min/m2; pulmonary wedge pressure, 30 mm Hg; right atrial pressure, 15 mm Hg. Total body water content was 16% above control, extracellular liquid was 33% above control, plasma volume was 34% above control, total exchangeable sodium was 37% above control, renal plasma flow was 29% of control, and glomerular filtration rate was 65% of control. Plasma norepinephrine was consistently increased (on average 6.3 times control), whereas adrenaline was unaffected. Although plasma renin activity and aldosterone varied widely, they were on average above normal (renin 9.5 times control, aldosterone 6.4 times control). Plasma atrial natriuretic peptide (14.3 times control) and growth hormone (11.5 times control) were consistently increased. Cortisol was also increased on average (1.7 times control). Vasopressin was increased only in one patient.

[1]  I. S. Anand,et al.  A simple automatic gamma counter based upon the IAEA radioimmunoassay instrument. , 1989, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[2]  P. Harris ROLE OF ARTERIAL PRESSURE IN THE OEDEMA OF HEART DISEASE , 1988, The Lancet.

[3]  J. Laragh,et al.  Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. , 1987, The American journal of cardiology.

[4]  J. Unsworth Some comments on plasma clearance by synthesis of continuous infusion. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  R. Ferrari,et al.  Release of atrial natriuretic peptide-like immunoreactive material during stretching of the rat atrium in vitro. , 1987, Journal of molecular and cellular cardiology.

[6]  P. Poole‐Wilson,et al.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.

[7]  G. Riegger,et al.  Human Atrial Natriuretic Peptide: Plasma Levels, Hemodynamic, Hormonal, and Renal Effects in Patients with Severe Congestive Heart Failure , 1986, Journal of cardiovascular pharmacology.

[8]  Chonacky Nj,et al.  Evaluation of plasma clearance by synthesis of continuous infusion: principles and use. , 1986 .

[9]  R. Taillefer,et al.  Correlation of left ventricular ejection fraction and plasma atrial natriuretic peptide in congestive heart failure. , 1986, The New England journal of medicine.

[10]  P. Erne,et al.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.

[11]  S. Ball,et al.  Plasma alpha natriuretic peptide in cardiac impairment. , 1986, British medical journal.

[12]  K. Swedberg,et al.  Increased plasma levels of atrial natriuretic peptide in patients with congestive heart failure. , 1986, European heart journal.

[13]  T. Satake,et al.  PLASMA ATRIAL NATRIURETIC FACTOR IN CONGESTIVE HEART FAILURE , 1986, The Lancet.

[14]  F. D. Thomas,et al.  Evaluation of plasma clearance by synthesis of continuous infusion: principles and use. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  A. Gerbes,et al.  Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[16]  R. Grekin,et al.  Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. , 1985, The Journal of clinical investigation.

[17]  B. Ludvik,et al.  ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN BLOOD FROM RIGHT ATRIUM IN PATIENT WITH SEVERE RIGHT HEART FAILURE , 1985, The Lancet.

[18]  I. Tikkanen,et al.  PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERS , 1985, The Lancet.

[19]  D. Ganten,et al.  Atrial natriuretic factor—a circulating hormone stimulated by volume loading , 1985, Nature.

[20]  J. Laragh,et al.  Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. , 1984, The American journal of medicine.

[21]  P. Harris Evolution and the cardiac patient. , 1983, Cardiovascular research.

[22]  A. Liuzzi,et al.  Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia. , 1982, The Journal of clinical endocrinology and metabolism.

[23]  N. Veall,et al.  The use of saliva samples to determine total body water by tritium dilution. , 1982, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[24]  G. Riegger,et al.  Antidiuretic hormone in congestive heart failure. , 1982, The American journal of medicine.

[25]  D. Goldstein,et al.  Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. , 1981, The American journal of cardiology.

[26]  T. Berl,et al.  Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. , 1981, The New England journal of medicine.

[27]  E. Kinney,et al.  Hemodynamic and metabolic responses to upright exercise in patients with congestive heart failure. Treatment with nitroglycerin ointment. , 1979, Chest.

[28]  R. Anderson,et al.  Mechanism of effect of hypoxia on renal water excretion. , 1978, The Journal of clinical investigation.

[29]  R. Underwood,et al.  38 – Mineralocorticoids: Aldosterone, Deoxycorticosterone, 18-Hydroxydeoxycorticosterone, and 18-Hydroxycorticosterone , 1978 .

[30]  F. Smith,et al.  The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. , 1976, The Journal of clinical investigation.

[31]  H. Cox,et al.  Letter: Moorgate tube disaster: disputed alcohol findings. , 1975, Lancet.

[32]  R. Anderson,et al.  Mechanism of effect of thoracic inferior vena cava constriction on renal water excretion. , 1974, The Journal of clinical investigation.

[33]  E. Espiner,et al.  Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. , 1974, Clinical science and molecular medicine.

[34]  C. Migeon,et al.  Integrated Concentration and Diurnal Variation of Plasma Cortisol1 , 1973 .

[35]  J. Brown,et al.  Renin relationships in congestive cardiac failure, treated and untreated. , 1970, American heart journal.

[36]  Y. Yamane Plasma ADH level in patients with chronic congestive heart failure. , 1968, Japanese circulation journal.

[37]  C. Sawin Measurement of plasma cortisol in the diagnosis of Cushing's syndrome. , 1968, Annals of internal medicine.

[38]  H. Schedl,et al.  AN EXPLANATION FOR ABNORMAL WATER RETENTION AND HYPOOSMOLALITY IN CONGESTIVE HEART FAILURE. , 1964, The American journal of medicine.

[39]  E. Braunwald,et al.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. , 1962, The New England journal of medicine.

[40]  J. Orloff,et al.  The pathogenesis of hyponatremia in congestive heart failure. , 1961, Progress in cardiovascular diseases.

[41]  F. Prunty ALDOSTERONE , 1960 .

[42]  A. Vander,et al.  Re-examination of salt and water retention in congestive heart failure: significance of renal filtration fraction. , 1958, The American journal of medicine.

[43]  I. Edelman,et al.  Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure. , 1958, The Journal of clinical investigation.

[44]  A. Fishman,et al.  THE BLOOD VOLUME IN HEART DISEASE , 1957, Medicine.

[45]  A. Barger The pathogenesis of sodium retention in congestive heart failure. , 1956, Metabolism: clinical and experimental.

[46]  I. Mirsky,et al.  The antidiuretic activity of plasma of patients with hepatic cirrhosis, congestive heart failure, hypertension and other clinical disorders. , 1954, The Journal of clinical investigation.

[47]  W. F. Perry,et al.  [Antidiuretic activity of the serum of normal and diseased subjects]. , 1953, The Journal of clinical endocrinology and metabolism.

[48]  A. Merrill,et al.  EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA. , 1946, The Journal of clinical investigation.

[49]  E. A. Stead,et al.  FLUID DYNAMICS IN CHRONIC CONGESTIVE HEART FAILURE: AN INTERPRETATION OF THE MECHANISMS PRODUCING THE EDEMA, INCREASED PLASMA VOLUME AND ELEVATED VENOUS PRESSURE IN CERTAIN PATIENTS WITH PROLONGED CONGESTIVE FAILURE , 1944 .